Farkhad Olzhayev

Dr. Farkhad Olzhayev

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
SASholpan Askarova
Sholpan Askarova
BUBauyrzhan Umbayev
Bauyrzhan Umbayev
Abdul-Razak MasoudAbdul-Razak Masoud
Abdul-Razak Masoud
AKAiym Kaiyrlykyzy
Aiym Kaiyrlykyzy
Yuliya Safarova (Yantsen)Yuliya Safarova (Yantsen)
Yuliya Safarova (Yantsen)
AKAlmagul Kushugulova
Almagul Kushugulova
Gut microbiome is a community of microorganisms in the gastrointestinal tract. These bacteria have a tremendous impact on the human physiology in healthy individuals and during an illness. Intestinal microbiome can influence one's health either directly by secreting biologically active substances such as vitamins, essential amino acids, lipids et cetera or indirectly by modulating metabolic processes and the immune system. In recent years considerable information has been accumulated on the relationship between gut microbiome and brain functions. Moreover, significant quantitative and qualitative changes of gut microbiome have been reported in patients with Alzheimer's disease. On the other hand, gut microbiome is highly sensitive to negative external lifestyle aspects, such as diet, sleep deprivation, circadian rhythm disturbance, chronic noise, and sedentary behavior, which are also considered as important risk factors for the development of sporadic Alzheimer's disease. In this regard, this review is focused on analyzing the links between gut microbiome, modern lifestyle, aging, and Alzheimer's disease.

26 May 2018 in Biogerontology
Verified
Journal Article
Closed access
PDF file
BUBauyrzhan Umbayev
Bauyrzhan Umbayev
Abdul-Razak MasoudAbdul-Razak Masoud
Abdul-Razak Masoud
ATAndrey Tsoy
Andrey Tsoy
DADauren Alimbetov
Dauren Alimbetov
FOFarkhad Olzhayev
Farkhad Olzhayev
SASholpan Askarova
Sholpan Askarova

Verified
Journal Article
Open access
PDF file
Yuliya Safarova (Yantsen)Yuliya Safarova (Yantsen)
Yuliya Safarova (Yantsen)
ANAssem Nessipbekova
Assem Nessipbekova
ASAizhan Syzdykova
Aizhan Syzdykova
FOFarkhad Olzhayev
Farkhad Olzhayev
BUBauyrzhan Umbayev
Bauyrzhan Umbayev
Julietta V. RauJulietta V. Rau
Julietta V. Rau
Background: Pathological bone fracturing is an escalating problem driven by increasing aging and obesity. Bioceramics, particularly tricalcium-phosphate-based materials (TCP), are renowned for their exceptional biocompatibility, osteoconductivity, and ability to promote biomineralization. In the present study, we designed and characterized TCP porous granules doped with strontium (Sr) and copper (Cu) (CuSr TCP). Sr2+ ions were selected as Sr plays a crucial role in early bone formation, osteogenesis, and angiogenesis; Cu2+ ions possess antibacterial properties. Materials: The synthesized CuSr TCP granules were characterized by X-ray diffraction. Cytotoxicity and cell proliferation analyses’ assays were performed through the lactate dehydrogenase (LDH) activity and CCK-8 viability tests in rat bone marrow-derived mesenchymal stem cells (BM-MSCs). Hemolytic activity was carried out with human red blood cells (RBCs). Early and late osteogenesis were assessed with alkaline phosphatase (ALP) and Alizarin Red S activity in human osteoblast progenitor cells and rat BM-MSCs. The influence of CuSr TCP on angiogenesis was investigated in human umbilical vein endothelial cells (HUVECs). Results: We have demonstrated that media enriched with CuSr TCP in concentrations ranging from 0.1 mg/mL to 1 mg/mL were not cytotoxic and did not significantly affect cell proliferation rate motility. Moreover, a concentration of 0.5 mg/mL showed a 2.5-fold increase in the migration potential of BM-MSCs. We also found that CuSr TCP-enriched media slightly increased early osteogenesis. We also found that Sr and Cu substitutions in TCP particles significantly enhanced the measured angiogenic parameters compared to control and unsubstituted TCP granules. Conclusion: Our results demonstrate that TCP porous granules doped with Sr and Cu are biocompatible, promote osteodifferentiation and angiogenesis, and could be recommended for further in vivo studies.

26 January 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
BZBalnur A. Zhaisanbayeva
Balnur A. Zhaisanbayeva
EMEllina Mun
Ellina Mun
LULeila Ulmanova
Leila Ulmanova
ZZZarina Zhunissova
Zarina Zhunissova
BUBauyrzhan Umbayev
Bauyrzhan Umbayev
Vitaliy KhutoryanskiyVitaliy Khutoryanskiy
Vitaliy Khutoryanskiy
This study comprises the comprehensive toxicological assessment of thiolated organosilica nanoparticles (NPs) synthesised from 3-mercaptopropyltrimethoxysilane (MPTS). We investigated the influence of three different types of nanoparticles synthesised from 3-mercaptopropyltrimethoxysilane: the starting thiolated silica (Si-NP-SH) and their derivatives prepared by surface PEGylation with PEG 750 (Si-NP-PEG750) and 5000 Da (Si-NP-PEG5000m) on biological subjects from in vitro to in vivo experiments to explore the possible applications of those nanoparticles in biomedical research. As a result of this study, we generated a comprehensive understanding of the toxicological properties of these nanoparticles, including their cytotoxicity in different cell lines, hemolytic properties, in vitro localisation, mucosal irritation properties and biodistribution in BALB/c mice. Our findings indicate that all three types of nanoparticles can be considered safe and have promising prospects for use in biomedical applications. Nanoparticles did not affect the viability of HPF, MCF7, HEK293 and A549 cell lines at low concentrations (up to 100 µg/mL); moreover, they did not cause organ damage to BALB/c mice at concentrations of 10 mg/kg. The outcomes of this study enhance our understanding of the impact of organosilica nanoparticles on health and the environment, which is vital for developing silica nanoparticle-based drug delivery systems and provides opportunities to expand the applications of organosilica nanoparticles.

29 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
BUBauyrzhan Umbayev
Bauyrzhan Umbayev
TSTimur Saliev
Timur Saliev
Yuliya Safarova (Yantsen)Yuliya Safarova (Yantsen)
Yuliya Safarova (Yantsen)
AYAislu Yermekova
Aislu Yermekova
FOFarkhad Olzhayev
Farkhad Olzhayev
SASholpan Askarova
Sholpan Askarova
Age-related obesity significantly increases the risk of chronic diseases such as type 2 diabetes, cardiovascular diseases, hypertension, and certain cancers. The insulin–leptin axis is crucial in understanding metabolic disturbances associated with age-related obesity. Rho GTPase Cdc42 is a member of the Rho family of GTPases that participates in many cellular processes including, but not limited to, regulation of actin cytoskeleton, vesicle trafficking, cell polarity, morphology, proliferation, motility, and migration. Cdc42 functions as an integral part of regulating insulin secretion and aging. Some novel roles for Cdc42 have also been recently identified in maintaining glucose metabolism, where Cdc42 is involved in controlling blood glucose levels in metabolically active tissues, including skeletal muscle, adipose tissue, pancreas, etc., which puts this protein in line with other critical regulators of glucose metabolism. Importantly, Cdc42 plays a vital role in cellular processes associated with the insulin and leptin signaling pathways, which are integral elements involved in obesity development if misregulated. Additionally, a change in Cdc42 activity may affect senescence, thus contributing to disorders associated with aging. This review explores the complex relationships among age-associated obesity, the insulin–leptin axis, and the Cdc42 signaling pathway. This article sheds light on the vast molecular web that supports metabolic dysregulation in aging people. In addition, it also discusses the potential therapeutic implications of the Cdc42 pathway to mitigate obesity since some new data suggest that inhibition of Cdc42 using antidiabetic drugs or antioxidants may promote weight loss in overweight or obese patients.

13 December 2014 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
RJR. Garrett Jeffries
R. Garrett Jeffries
YMYerbol Mussin
Yerbol Mussin
DBDenis S. Bulanin
Denis S. Bulanin
LLLaura W. Lund
Laura W. Lund
EKErgin Kocyildirim
Ergin Kocyildirim
PWPeter D. Wearden
Peter D. Wearden
The objective of this work was to conduct pre-clinical feasibility studies to determine if a highly efficient, active-mixing, adult extracorporeal carbon dioxide removal (ECCO2R) system can safely be translated to the pediatric population. The Hemolung Respiratory Assist System (RAS) was tested in vitro and in vivo to evaluate its performance for pediatric veno-venous applications. The Hemolung RAS operates at blood flows of 350-550 ml/min and utilizes an integrated pump-gas exchange cartridge with a membrane surface area of 0.59 m2 as the only component of the extracorporeal circuit. Both acute and seven-day chronic in vivo tests were conducted in healthy juvenile sheep using a veno-venous cannulation strategy adapted to the in vivo model. The Hemolung RAS was found to have gas exchange and pumping capabilities relevant to patients weighing 3-25 kg. Seven-day animal studies in juvenile sheep demonstrated that veno-venous extracorporeal support could be used safely and effectively with no significant adverse reactions related to device operation.